Tau-positron emission tomography correlates with neuropathology findings.

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 1×

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050

Primary age-related tauopathy (PART): a common pathology associated with human aging

Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467

Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies

Coughlin, D. G., Hiniker, A. O., Peterson, C. S., Kim, Y., Arezoumandan, S., Giannini, L., Pizzo, D. P., Weintraub, D. A., Siderowf, A. D., Litvan, I., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac094 · Cited by 15

Biomarker-related phospho-tau217 appears in synapses around Aβ plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer’s disease

Hirota, Y., Sakakibara, Y., Morishima, M., Sano, T., Hara, M., Arakawa, A., Takao, M., Murayama, S., Saito, Y., Sekiya, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116203 · Cited by 15

Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study

Wagatsuma, K., Miwa, K., Akamatsu, G., Yamao, T., Kamitaka, Y., Sakurai, M., Fujita, N., Hanaoka, K., Matsuda, H., & Ishii, K. (2023) · Annals of Nuclear Medicine · doi:10.1007/s12149-023-01847-8 · Cited by 13

Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation

Wright, J. P., Goodman, J. R., Lin, Y., Lieberman, B. P., Clemens, J., Gomez, L. F., Liang, Q., Hoye, A. T., Pontecorvo, M. J., & Conway, K. A. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05822-9 · Cited by 13

Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study

Casteele, T. V., Laroy, M., Cauwenberge, M. G. A. V., Vanderlinden, G., Vansteelandt, K., Koole, M. J. B., Dupont, P. J., Bossche, M. J. A. V. D., den Stock, J. V., Bouckaert, F., et al. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.07.005 · Cited by 13

Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography

Josephs, K. A., Tosakulwong, N., Gatto, R. G., Weigand, S. D., Ali, F., Botha, H., Graff‐Radford, J., Machulda, M. M., Savica, R., Schwarz, C. G., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26479 · Cited by 13

Tau filaments with the Alzheimer fold in cases with MAPT mutations V337M and R406WPreprint

Qi, C., Lövestam, S., Murzin, A. G., Peak‐Chew, S., Franco, C. D. M. F., Bogdani, M., Latimer, C. S., Murrell, J. R., Cullinane, P. W., Jaunmuktane, Z., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591661 · Cited by 11

Association of [ 18 F]Flortaucipir–PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders

Vrillon, A., Spina, S., Mejía‐Perez, J. A., LaMore, T., Yballa, C., Soleimani‐Meigooni, D. N., Blazhenets, G., Boxer, A. L., Rojas, J. C., Lago, A. L., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214576 · Cited by 14

Plasma p-tau217 predicting brain-wide tau accumulation in preclinical AD

Moon, H., & Chen, X. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100252 · Cited by 12

The Role of Clinical Assessment in the Era of Biomarkers

Carlos, A. F., & Josephs, K. A. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01410-3 · Cited by 11

Update on neuroimaging in Alzheimer's disease

Sintini, I., & Whitwell, J. L. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000947 · Cited by 10

Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyPreprint

Ossenkoppele, R., Salvadó, G., Janelidze, S., Binette, A. P., Bali, D., Karlsson, L., Palmqvist, S., Mattsson, N., Stomrud, E., Therriault, J., et al. (2024) · medRxiv · doi:10.1101/2024.06.12.24308824 · Cited by 10

Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology

Martersteck, A., Ayala, I., Ohm, D. T., Spencer, C., Coventry, C., Weintraub, S., Bigio, E. H., Mesulam, M. M., Geula, C., & Rogalski, E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01412-w · Cited by 9

Rates of clinical progression according to biological Alzheimer's disease stages

Trudel, L., Therriault, J., Macedo, A. C., Servaes, S., Hosseini, S. A., Bezgin, G., Rahmouni, N., Chan, T., Arias, J. F., Aumont, É., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70624 · Cited by 13

Multimodal cross‐examination of progressive apraxia of speech by diffusion tensor imaging‐based tractography and Tau‐PET scans

Gatto, R. G., Pham, N. T. T., Duffy, J. R., Clark, H. M., Utianski, R. L., Botha, H., Machulda, M. M., Lowe, V. J., Schwarz, C. G., Jack, C. R., et al. (2024) · Human Brain Mapping · doi:10.1002/hbm.26704 · Cited by 10

Microscopy assessment of a fluorescence [ 18 F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions

Gatto, R. G., Youssef, H., Reichard, R. R., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14330 · Cited by 8

Survey among experts on the future role of tau‐PET in clinical practice and trials

Vermeiren, M. R., Calandri, I. L., van der Flier, W. M., van de Giessen, E., & Ossenkoppele, R. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70033 · Cited by 10

Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison

Chen, Y., Joie, R. L., Pereira, F. L., Blazhenets, G., Zhu, L., Spina, S., Seeley, W. W., Heinsen, H., Ushizima, D. M., Tosun, D., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02983-x · Cited by 12

SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline

Toledo, J. B., Rashid, T., Liu, H., Launer, L. J., Shaw, L. M. J., Heckbert, S. R., Weiner, M. W., Seshadri, S. S., Habes, M., & Initiative, A. D. N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276392 · Cited by 8

Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases

Corriveau‐Lecavalier, N., Barnard, L. R., Botha, H., Graff‐Radford, J., Ramanan, V. K., Lee, J., Dicks, E., Rademakers, R., Boeve, B. F., Machulda, M. M., et al. (2023) · Brain · doi:10.1093/brain/awad356 · Cited by 10

The Overlap Index as a means of evaluating early tau-PET signal reliability

Lee, J., Burkett, B. J., Min, H.-K. P., Lundt, E. S., Albertson, S. M., Botha, H., Senjem, M. L., Gunter, J. L., Schwarz, C. G., Jones, D. G., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263136 · Cited by 8

Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy

Tremblay, C., Serrano, G. E., Intorcia, A. J., Curry, J. R., Sue, L. I., Nelson, C. M., Walker, J. E., Glass, M. J., Arce, R. A., Fleisher, A., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac008 · Cited by 8

Significance of a positive tau PET scan with a negative amyloid PET scan

Robinson, C. G., Lee, J., Min, H.-K. P., Przybelski, S. A., Josephs, K. A., Jones, D. T., Graff‐Radford, J., Boeve, B. F., Knopman, D. S., Jack, C. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13608 · Cited by 8

Hippocampal subregional volume changes in elders classified using positron emission tomography‐based Alzheimer's biomarkers of β‐amyloid deposition and neurodegeneration

Busatto, G. F., Duran, F., Squarzoni, P., Coutinho, A. M., Rosa, P. G. P., Torralbo, L., Pachi, C. G. D. F., da Costa, N. A., Porto, F. H. D. G., Carvalho, C. L., et al. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24739 · Cited by 7

Imaging Tau Pathology—The Next Step

Jagust, W. J. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0520 · Cited by 7

Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [18F]flortaucipir imaging: TAU-SPEX

Coomans, E. M., van Tol, B. G. J., Groot, C., Smith, R. A., Palmqvist, S., Stomrud, E., Pontecorvo, M. J., Shcherbinin, S., Kennedy, I. A., Kotari, V., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07384-y · Cited by 6

Clinical–biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data

Trudel, L., Therriault, J., Macedo, A. C., Hosseini, S. A., Arias, J. F., Chan, T., Rahmouni, N., Bezgin, G., Tissot, C., Woo, M. S., et al. (2026) · Brain · doi:10.1093/brain/awag018 · Cited by 8

Correlation of early-phase β-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer’s disease

Völter, F., Eckenweber, S., Scheifele, M., Eckenweber, F., Hirsch, F., Franzmeier, N., Kreuzer, A., Griessl, M., Steward, A., Janowitz, D., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07175-5 · Cited by 6

Relationships between hypometabolism and both β‐amyloid and tau PET in corticobasal syndrome

Ghirelli, A., Goodrich, A. W., Stephens, Y. C., Graff‐Radford, J., Ali, F., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Agosta, F., Filippi, M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70018 · Cited by 8

Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease

Colato, E., Initiative, A. D. N., Chiotis, K., Ferreira, D., Mazrina, M. S., Lemoine, L., Mohanty, R., Westman, E., Nordberg, A. K., & Rodriguez‐Vieitez, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210614 · Cited by 7

Imaging Alzheimer’s pathology stage by stage

Malpetti, M., & Joie, R. L. (2022) · Nature Aging · doi:10.1038/s43587-022-00236-6 · Cited by 6

Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s diseasePreprint

Xiao, Y., Spotorno, N., An, L., Bazinet, V., Hansen, J. Y., Strandberg, O. T., Shafiei, G., Behjat, H., Funck, T., Salvadó, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.648358 · Cited by 6

The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

Vermeiren, M. R., Somsen, J. F., Luurtsema, G., Reesink, F. E., Verwey, N. A., Hempenius, L., Tolboom, N., Biessels, G. J., Biesbroek, J. M., Vernooij, M. W., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01588-4 · Cited by 5

White matter hyperintensities and TDP‐43 pathology in Alzheimer's disease

Carlos, A. F., Weigand, S. D., Pham, N. T. T., Petersen, R. C., Jack, C. R., Dickson, D. W., Whitwell, J. L., & Josephs, K. A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14516 · Cited by 5

Three‐dimensional histology reveals dissociable human hippocampal long‐axis gradients of Alzheimer's pathology

Ortega‐Cruz, D., Bress, K. S., Gazula, H., Rábano, A., Iglesias, J. E., & Strange, B. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13695 · Cited by 5

Investigating the feasibility of 18F‐flortaucipir PET imaging in the antemortem diagnosis of primary age‐related tauopathy (PART): An observational imaging‐pathological study

Lavrova, A., Satoh, R., Pham, N. T. T., Nguyen, A. T., Jack, C. R., Petersen, R. C., Ross, R. R., Dickson, D. W., Lowe, V. J., Whitwell, J. L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14301 · Cited by 6

Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.

Dickerson, B. C., & Atri, A. (2020) · PubMed · Cited by 5

Dynamic Aphasia as a Variant of Frontotemporal Dementia

Chandregowda, A., Clark, H. M., Duffy, J. R., Machulda, M. M., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2021) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000289 · Cited by 5

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s diseasePreprint

Rubinski, A., Franzmeier, N., Dewenter, A., Luan, Y., Smith, R. A., Strandberg, O. T., Ossenkoppele, R., Dichgans, M., Hansson, O., Ewers, M., et al. (2022) · medRxiv · doi:10.1101/2022.03.02.22271746 · Cited by 5

A limbic-predominant amnestic neurodegenerative syndrome associated with TDP-43 pathologyPreprint

Corriveau‐Lecavalier, N., Botha, H., Graff‐Radford, J., Switzer, A. R., Przybelski, S. A., Wiste, H. J., Murray, M. E., Reichard, R. R., Dickson, D. W., Nguyen, A. T., et al. (2023) · medRxiv · doi:10.1101/2023.11.19.23298314 · Cited by 5

Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo

Therriault, J., Gauthier, S. G., & Rosa‐Neto, P. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.52 · Cited by 4

18 F‐FDG PET in detection of primary age‐related tauopathy (PART) – Is there a role? Insights from an imaging‐pathology correlation study

Lavrova, A., Pham, N. T. T., Vernon, C. J., Graff‐Radford, J., Boeve, B. F., Knopman, D. S., Kantarci, K., Jack, C. R., Nguyen, A. T., Ross, R. R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70568 · Cited by 4

Neuroinflammation demonstrated by 11 C‐ER176 PET with amyloid and tau pathology

Kandimalla, M., Lim, S., Jacobson, D. N., Lee, J., Min, P. H., Nycklemoe, M., Lee, S. B., Lundt, E. S., Botha, H., Graff‐Radford, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71027 · Cited by 4

Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition

Cogswell, P. M., Lundt, E. S., Therneau, T. M., Hu, M., Griswold, M. E., Wiste, H. J., Machulda, M. M., Stricker, N. H., Braunstein, J. B., West, T., et al. (2026) · Brain · doi:10.1093/brain/awag075 · Cited by 4

Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers

Stehouwer, J. S., Huang, G., Guarino, D. S., Debnath, M. L., Polu, A., Geib, S. J., Lopresti, B. J., Ikonomović, M. D., Mason, N. S., Mach, R. H., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02988 · Cited by 4

Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease

Quattrini, G., Ferrari, C., Pievani, M., Geviti, A., Ribaldi, F., Scheffler, M., Frisoni, G. B., Garibotto, V., Marizzoni, M., & Initiative, A. D. N. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06280-7 · Cited by 4

The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review

Nasrallah, I. M., Kuo, P. H., Nordberg, A. K., Bohnen, N. I., & Ponisio, M. R. (2025) · American Journal of Roentgenology · doi:10.2214/ajr.24.32325 · Cited by 4

The Biomarker Profile of Alzheimer’s Disease for Disease-Modifying Treatment Eligibility: Questions and Debates

Athanasaki, A., Tsantzali, I., Theodorou, A., Michalopoulou, A., Constantinides, V. C., Boufidou, F., Tzartos, J. S., Tsalouchidou, P., Zompola, C., Paraskevas, S. G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199531 · Cited by 3

Spatial patterns of tau accumulation across the Alzheimer's disease spectrum

Fonseca, C. S., Chao, Y., Joie, R. L., Rabinovici, G. D., Jagust, W. J., Harrison, T. M., & Initiative, A. D. N. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71076 · Cited by 3

Neuropathological correlates of age and sex differences in 18F-flortaucipir PET

Coomans, E. M., Smith, R. A., Pawlik, D., Hauer, K. O., Palmqvist, S., Stomrud, E., Mattsson, N., Tremblay, C., Serrano, G. E., Beach, T. G., et al. (2026) · Brain · doi:10.1093/brain/awag136 · Cited by 3

LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy

Ramanan, V. K., & Graff‐Radford, J. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001499 · Cited by 4

Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer’s disease continuum

Protas, H. D., Ghisays, V., Goradia, D. D., Bauer, R., Devadas, V., Chen, K., Reiman, E. M., & Su, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1089134 · Cited by 4

Tau positron emission tomography in tauopathies: A narrative review

Lee, H., Gu, Y., Seo, S. W., & Moon, S. H. (2023) · Precision and Future Medicine · doi:10.23838/pfm.2023.00016 · Cited by 4

Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PET

Nakamura, K., Kuroha, Y., Hatakeyama, M., Kimura, A., Nakamura, Y., Murakami, Y., Watanabe, M., Igarashi, H., Takahashi, T., & Shimada, H. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04564-z · Cited by 3

PET Imaging of Amyloid and Tau in Alzheimer’s Disease

Okamura, N., & Harada, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_19 · Cited by 3

Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

Rikken, R. M., Coomans, E. M., de Koning, L. A., Visser, D., Neutelings, E., den Braber, A., Collij, L. E., Golla, S. S. V., Initiative, A. D. N., Barkhof, F., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14423 · Cited by 2

The study of plaques and tangles makes few and inaccurate predictions about the main features of cognitive disorders: A narrative review

Abbate, C., & Gallucci, A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374319 · Cited by 2

Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease

Brendel, M., Kuo, P. H., Brumberg, J., Doré, V., Drzezga, A. E., Garibotto, V., Leuzy, A., Mathoux, G., Meyer, P. T., Moscoso, A., et al. (2026) · The EANM Journal · doi:10.1016/j.eanmj.2026.100214 · Cited by 3

Towards in vivo PET imaging of primary age-related tauopathy

Therriault, J., & Grothe, M. J. (2023) · Brain · doi:10.1093/brain/awad210 · Cited by 2

Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech

Tetzloff, K. A., Duffy, J. R., Clark, H. M., Pham, N. T. T., Machulda, M. M., Botha, H., Jack, C. R., Dickson, D. W., Lowe, V. J., Josephs, K. A., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230912 · Cited by 2

Association of [ 18 F]Flortaucipir-PET and plasma p-tau217 with tau neuropathology in AD and other neurodegenerative disordersPreprint

Vrillon, A., Spina, S., Mejía‐Perez, J. A., LaMore, T., Yballa, C., Soleimani‐Meigooni, D. N., Blazhenets, G., Boxer, A. L., Rojas, J. C., Lago, A. L., et al. (2025) · medRxiv · doi:10.1101/2025.05.14.25326954 · Cited by 2

Case report: pre-symptomatic clinical and metabolic profile in posterior cortical atrophy and dementia with Lewy bodies

Shir, D., Corriveau‐Lecavalier, N., Graff‐Radford, J., Machulda, M. M., Knopman, D. S., Petersen, R. C., Nguyen, A. T., Dickson, D. W., & Jones, D. T. (2024) · Neurocase · doi:10.1080/13554794.2024.2348223 · Cited by 1

An appraisal on biomolecular imaging in diagnosis of neurological disorders and innovation in clinical research

Katiyar, D., & Manish, M. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100126 · Cited by 1

Fully individualized models for cross-sectional and longitudinal network-based tau spread

Brown, C., Das, S. R., Detre, J. A., Nasrallah, I. M., Yushkevich, P. A., McMillan, C. T., & Wolk, D. A. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.1053 · Cited by 1

Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy‐confirmed co‐pathologies

Chen, C. D., Agüero, C., Melloni, A. N., Healy, B. C., Thibault, E. G., Fu, J. F., Farrell, M. E., Schultz, S. A., Yang, H., Bellier, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71092 · Cited by 1

Improving neuropathological reconstruction fidelity via AI slice imputation

Aguirre, M., Williams-Ramirez, J., Zemlyanker, D., Hu, X., Deden-Binder, L. J., Herisse, R., Montine, M., Connors, T. R., Mount, C., MacDonald, C. L., et al. (2026) · Acta Neuropathologica Communications · doi:10.21203/rs.3.rs-9117500/v1 · Cited by 1

Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer’s disease

Macedo, A. C., Trudel, L., Hosseini, S. A., Therriault, J., Aumont, É., Bezgin, G., Rahmouni, N., Stevenson, J., Tissot, C., Woo, M. S., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00945-1 · Cited by 3

A probabilistic framework for clinicopathological Alzheimer’s disease using tau-PET

van Tol, B. G. J., Groot, C., Vermeiren, M. R., van de Giessen, E., Pijnenburg, Y. A. L., Coomans, E. M., & Ossenkoppele, R. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02133-1 · Cited by 1

Patterns of amyloid accumulation in amyloid-negative cases

Alchera, N., Garibotto, V., Tomczyk, S., Treyer, V., Höck, C., Gietl, A. F., Lövblad, K., Scheffler, M., Chincarini, A., Frisoni, G. B., et al. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.05.006 · Cited by 2

Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer’s Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy

Robinson, C. G., Coleman, T., Buciuc, M., Singh, N. A., Pham, N. T. T., Machulda, M. M., Graff‐Radford, J., Whitwell, J. L., & Josephs, K. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230652 · Cited by 1

Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development

Huang, Y. H., Jia, H., & Bao, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00013-6

16.MRCTにて海馬の萎縮が認められた恐怖性障害の1例(第15回日本心身医学会近畿地方会演題抄録)

上田, 文., 飯田, 順., 田原, 宏., & 井川, 玄. (1992) · 心身医学

Construction and implementation of regional high-level PET alliance based on international consensus

Yang, J., & Lv, Z. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05796-8

Perception-Enhanced Generative Adversarial Network for Synthesizing Tau Positron Emission Tomography images from Structural Magnetic Resonance Images: a cross-center and cross-tracer studyPreprint

Jiang, J., Sun, J., Xue, L., Lu, J., Zhang, Q., Zhang, S., Wang, L., Wang, M., Zuo, C., & Tian, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3399187/v1

PET and SPECT imaging as a solid guide to detect and discriminate atypical phenotypes of neurodegenerative disorders

Nuclear Medicine Division, A. O. –. U. D. P., Ruffini, L., Zilioli, A., Neurology Division, A. O. –. U. D. P., Cervati, V., Nuclear Medicine Division, A. O. –. U. D. P., Lauretani, F., Misirocchi, F., Neurology Division, A. O. –. U. D. P., Maggio, M. G., et al. (2024) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2024.1.20 · Cited by 1

Multi region dissection of Alzheimer's brain at single cell level

Mao, M., Wang, C., Ma, X., & Ye, J. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.010

Clinical investigation cases studies and critical thinking problem approaches

ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00010-8

Imaging Markers of Amyloid and Tau in Alzheimer Disease

Tarawneh, R. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_20

Optimized Quantitative Susceptibility Mapping at 7T MRI for Assessing Iron deposition in Alzheimer’s DiseasePreprint

Ma, F., Özbay, P. S., Bilgiç, B., Hedden, T., Delman, B. N., Balchandani, P., & Alipour, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.31.673334

Prediction of future brain disorder risk using imaging data in 46,090 adultsPreprint

Tie, Y., Zhong, S., Yang, W., Pan, L., Yang, L., Duan, J., Li, H., Sai, K., Chen, S., Li, Z., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7238162/v1

Evaluation of a Sensitive Visual Read Algorithm for Assessing 3R/4R Tau PET Images

Smith, R. A., Garibotto, V., Hägerström, D., Jögi, J., Ohlsson, T. G., Strandberg, O. T., Tonietto, M., Janelidze, S., Palmqvist, S., Stomrud, E., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.269685

Cerebrospinal Fluid, Molecular Neuroimaging, and Blood Biomarkers of Neurodegenerative Disease: Past, Present, and Future

Soleimani‐Meigooni, D. N., & Rabinovici, G. D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.006

Additional file 1 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571886

Additional file 1 of Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Murray, M. E., Moloney, C. M., Kouri, N., Syrjanen, J. A., Matchett, B. J., Rothberg, D. M., Tranovich, J. F., Sirmans, T. N. H., Wiste, H. J., Boon, B. D. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26557766

Additional file 1 of Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review

Asken, B. M., & Rabinovici, G. D. (2021) · Figshare · doi:10.6084/m9.figshare.14651208

Additional file 5 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571898

Additional file 3 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571892

Additional file 4 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571895

Additional file 2 of Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression

Kotari, V., Southekal, S. S., Navitsky, M. A., Kennedy, I. A., Lu, M., Morris, A., Zimmer, J. A., Fleisher, A. S., Mintun, M. A., Devous, M. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26571889

Tau PET overlap index correlation with neuropathological findings

Lim, S., Lee, J., Min, P. H., Moloney, C. M., Mester, C. T., Ghatamaneni, S., Senjem, M. L., Botha, H., Knopman, D. S., McCarter, S. J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71241

Optimized Quantitative Susceptibility Mapping at 7T MRI for Assessing Iron Deposition in Alzheimer's Disease

Ma, F., Özbay, P. S., Bilgiç, B., Hedden, T., Delman, B. N., Balchandani, P., & Alipour, A. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70268

Expert consensus on communicating tau PET results to persons living with MCI or dementia: Findings from a modified Delphi study

Erickson, C. M., O'Brien, K. O., Largent, E. A., Harkins, K. A., Coykendall, C., Kleid, M., Clapp, J. T., & Karlawish, J. H. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71321

Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS

Hammers, D. B., Polsinelli, A. J., Eloyan, A., Taurone, A., Thangarajah, M., Foroud, T., Gao, S., Beckett, L. A., Joie, R. L., Touroutoglou, A., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70342

Correlation between in vivo 18 F‐flortaucipir PET and whole‐brain postmortem histological tau signals in Alzheimer's disease

Chao, Y., Chen, Y., Chadwick, T. A., Harrison, T. M., Iaccarino, L., Heinsen, H., Ushizima, D. M., Tosun, D., Jagust, W. J., & Grinberg, L. T. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71453 · Cited by 1

Manifold diffusion transformer enables diagnostic multi-tracer PET synthesis from MRI for early detection of Alzheimer’s disease

Wang, C., Piao, S., Wang, J., Li, Z., Chen, T., Cui, M., Zhao, J., Guo, Q., Zhang, J., Xie, F., et al. (2026) · The Innovation Informatics · doi:10.59717/j.xinn-inform.2026.100048 · Cited by 1

Geometric brain signatures of Alzheimer’s disease progression and subtypesPreprint

Tong, B., Cao, T., Duong-Tran, D., Davatzikos, C. A., Thompson, P. M., Saykin, A. J., Fornito, A., Shen, L., & Initiative, T. F. L. D. N. (2026) · medRxiv · doi:10.64898/2026.05.14.26353211

Brain tau network derived biomarker improves the diagnostic accuracy of Alzheimer’s disease

Pan, T., Zhou, Q., Li, P., Nie, B., Li, N., Yang, H., Shan, B., & Li, W. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111962

Concordance between plasma biomarkers of phosphorylated tau and tau-PET: A narrative review

van Houwelingen, A., Vernooij, M. W., Vermeiren, M. R., Ossenkoppele, R., van de Giessen, E., Seelaar, H., & Neitzel, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261468708

Prospective study on physical activity and Alzheimer's disease–related biomarkers

Iso‐Markku, P., Tu, X. M., Rissman, R. A., Gillespie, N. A., Elman, J. A., Fennema‐Notestine, C., Panizzon, M. S., Reynolds, C. A., Lyons, M. J., Kremen, W. S., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71755

50µm ex vivo MRI reveals distant layer-specific hippocampal atrophy in early Alzheimer's diseasePreprint

Salman, Y., Tomé, S. O., Joudiou, N., Annettesdotter, A., Khandelwal, P., Lawson, T. M., Behets, C., Lengelé, B., Thal, D. R., Yushkevich, P. A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10800434/v1

[18F]Flortaucipir PET to Autopsy Pathology Correlation in Alzheimer’s Disease and Other Neurodegenerative Diseases (2630)

Soleimani‐Meigooni, D. N., Iaccarino, L., Joie, R. L., Baker, S. L., Bourakova, V., Boxer, A. L., Edwards, L., Eser, R. A., Gorno‐Tempini, M. L., Jagust, W. J., et al. (2020) · Neurology · doi:10.1212/wnl.94.15_supplement.2630

O4‐12‐01: TAU PET IMAGING CORRELATES WITH NEUROPATHOLOGY

Lowe, V. J., Lundt, E. S., Albertson, S. M., Nancy, S., Min, H.-K. P., Fang, P., Senjem, M. L., Schwarz, C. G., Parisi, J. E., Kantarci, K., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.4806

Correlation between in vivo 18 F‐flortaucipir PET and whole‐brain postmortem histological tau signals in Alzheimer's disease

Chao, Y., Chen, Y., Chadwick, T. A., Harrison, T. M., Iaccarino, L., Heinsen, H., Ushizima, D. M., Tosun, D., Jagust, W. J., & Grinberg, L. T. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71453 · Cited by 1

[18F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases

Soleimani‐Meigooni, D. N., Iaccarino, L., Joie, R. L., Baker, S. L., Bourakova, V., Boxer, A. L., Edwards, L., Eser, R. A., Tempini, M. L. G., Jagust, W. J., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.046262 · Cited by 1

P2‐439: [18F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON‐ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES

Soleimani‐Meigooni, D. N., Iaccarino, L., Joie, R. L., Lesman‐Segev, O. H., Bourakova, V., Strom, A., Edwards, L., Baker, S. L., Janabi, M., Eser, R. A., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.2846